Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 825

    1.

    Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target.

    Chen Y, Clegg NJ, Scher HI.

    Lancet Oncol. 2009 Oct;10(10):981-91.PMID: 19796750 [PubMed - indexed for MEDLINE]Related articles

    2.

    2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer.

    Pillarsetty N, Punzalan B, Larson SM.

    J Nucl Med. 2009 Oct;50(10):1709-14. Epub 2009 Sep 16.PMID: 19759108 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.

    Mazaheri Y, Hricak H, Fine SW, Akin O, Shukla-Dave A, Ishill NM, Moskowitz CS, Grater JE, Reuter VE, Zakian KL, Touijer KA, Koutcher JA.

    Radiology. 2009 Aug;252(2):449-57.PMID: 19703883 [PubMed - indexed for MEDLINE]Related articles

    4.

    Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue.

    Rabbani F, Vora KC, Yunis LH, Eastham JA, Guillonneau B, Scardino PT, Touijer K.

    BJU Int. 2009 Sep;104(5):605-10.PMID: 19689577 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors.

    Haarer CF, Gopalan A, Tickoo SK, Scardino PT, Eastham JA, Reuter VE, Fine SW.

    J Urol. 2009 Oct;182(4):1337-41. Epub 2009 Aug 14.PMID: 19683261 [PubMed - indexed for MEDLINE]Related articles

    6.

    Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors.

    Mosher CE, Sloane R, Morey MC, Snyder DC, Cohen HJ, Miller PE, Demark-Wahnefried W.

    Cancer. 2009 Sep 1;115(17):4001-9.PMID: 19637244 [PubMed - indexed for MEDLINE]Related articles

    7.

    NF-kappaB regulates androgen receptor expression and prostate cancer growth.

    Zhang L, Altuwaijri S, Deng F, Chen L, Lal P, Bhanot UK, Korets R, Wenske S, Lilja HG, Chang C, Scher HI, Gerald WL.

    Am J Pathol. 2009 Aug;175(2):489-99. Epub 2009 Jul 23.PMID: 19628766 [PubMed - indexed for MEDLINE]Related articles

    8.

    Prostate size is associated with surgical difficulty but not functional outcome at 1 year after radical prostatectomy.

    Pettus JA, Masterson T, Sokol A, Cronin AM, Savage C, Sandhu JS, Mulhall JP, Scardino PT, Rabbani F.

    J Urol. 2009 Sep;182(3):949-55. Epub 2009 Jul 17.PMID: 19616260 [PubMed - indexed for MEDLINE]Related articles

    9.

    Do high-volume hospitals and surgeons provide better care in urologic oncology?

    Eastham JA.

    Urol Oncol. 2009 Jul-Aug;27(4):417-21. Review.PMID: 19573772 [PubMed - indexed for MEDLINE]Related articles

    10.

    Nomograms for staging, prognosis, and predicting treatment outcomes.

    Touijer K, Scardino PT.

    Cancer. 2009 Jul 1;115(13 Suppl):3107-11. Review.PMID: 19544538 [PubMed - indexed for MEDLINE]Related articles

    11.

    In vivo lactate signal enhancement using binomial spectral-selective pulses in selective MQ coherence (SS-SelMQC) spectroscopy.

    Thakur SB, Yaligar J, Koutcher JA.

    Magn Reson Med. 2009 Sep;62(3):591-8.PMID: 19526486 [PubMed - indexed for MEDLINE]Related articles

    12.

    From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine.

    Zhu J, Wan Q, Lee D, Yang G, Spassova MK, Ouerfelli O, Ragupathi G, Damani P, Livingston PO, Danishefsky SJ.

    J Am Chem Soc. 2009 Jul 8;131(26):9298-303.PMID: 19518111 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.

    O'Brien MF, Cronin AM, Fearn PA, Smith B, Stasi J, Guillonneau B, Scardino PT, Eastham JA, Vickers AJ, Lilja H.

    J Clin Oncol. 2009 Aug 1;27(22):3591-7. Epub 2009 Jun 8.PMID: 19506163 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.

    Shukla-Dave A, Hricak H, Ishill N, Moskowitz CS, Drobnjak M, Reuter VE, Zakian KL, Scardino PT, Cordon-Cardo C.

    Clin Cancer Res. 2009 Jun 1;15(11):3842-9. Epub 2009 May 12.PMID: 19435838 [PubMed - indexed for MEDLINE]Related articles

    15.

    The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer.

    Fuchsjäger M, Akin O, Shukla-Dave A, Pucar D, Hricak H.

    Clin Adv Hematol Oncol. 2009 Mar;7(3):193-202. Review.PMID: 19398944 [PubMed - indexed for MEDLINE]Related articles

    16.

    Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.

    Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, Alimonti A, Nardella C, Varmeh S, Scardino PT, Cordon-Cardo C, Gerald W, Pandolfi PP.

    Nat Genet. 2009 May;41(5):619-24. Epub 2009 Apr 26.PMID: 19396168 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis.

    King JC, Xu J, Wongvipat J, Hieronymus H, Carver BS, Leung DH, Taylor BS, Sander C, Cardiff RD, Couto SS, Gerald WL, Sawyers CL.

    Nat Genet. 2009 May;41(5):524-6. Epub 2009 Apr 26.PMID: 19396167 [PubMed - indexed for MEDLINE]Related articles

    18.

    Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer.

    Morris MJ, Huang D, Kelly WK, Slovin SF, Stephenson RD, Eicher C, Delacruz A, Curley T, Schwartz LH, Scher HI.

    Eur Urol. 2009 Aug;56(2):237-44. Epub 2009 Apr 3.PMID: 19375217 [PubMed - indexed for MEDLINE]Related articles

    19.

    The role and structure of a postradical prostatectomy penile rehabilitation program.

    Mulhall JP.

    Curr Urol Rep. 2009 May;10(3):219-25. Review.PMID: 19371480 [PubMed - indexed for MEDLINE]Related articles

    20.

    Critical appraisal of outcomes following open radical prostatectomy.

    Galvin DJ, Eastham JA.

    Curr Opin Urol. 2009 May;19(3):297-302. Review.PMID: 19365894 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...